JC Wasmuth

Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men

Use of therapeutic drug monitoring in HIV disease

The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview

Impact of HIV Infection and HAART on Serum Lipids in Men

Antiretroviral Treatment of Adult HIV Infection

Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success

Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4

Sexually Transmitted Infections Treatment Guidelines, 2021

Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease

Sexually Transmitted Diseases Treatment Guidelines, 2010

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Computerized advice on drug dosage to improve prescribing practice

Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV‐1 co‐infected patients

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Influence of protease inhibitor therapy on lipoprotein metabolism

Liver Fibrosis Progression After Acute Hepatitis C Virus Infection in HIV-Positive Individuals

Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity

Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.